Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.367 USD | +1.35% | -8.25% | -97.99% |
Chart calendar Panbela Therapeutics, Inc.
Upcoming events on Panbela Therapeutics, Inc.
Past events on Panbela Therapeutics, Inc.
2024-05-21 02:00 pm | Digestive Disease Week Conference |
2024-05-15 04:30 pm | Q1 2024 Earnings Call |
2024-05-15 04:10 pm | Q1 2024 Earnings Release |
2024-05-03 03:00 pm | Extraordinary Shareholders Meeting |
2024-04-10 12:00 pm | American Association for Cancer Research Meeting - Abstract No: 7154 |
2024-03-26 04:30 pm | Q4 2023 Earnings Call |
2024-03-26 04:10 pm | Q4 2023 Earnings Release |
2024-03-18 11:30 am | Roth Conference |
2023-12-19 03:30 pm | Extraordinary Shareholders Meeting |
2023-11-09 04:30 pm | Q3 2023 Earnings Call |
2023-11-09 04:10 pm | Q3 2023 Earnings Release |
2023-10-04 06:30 pm | LD Micro Main Event Conference |
2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
2023-08-10 04:30 pm | Q2 2023 Earnings Call |
2023-08-10 04:10 pm | Q2 2023 Earnings Release |
2023-06-21 11:00 am | Maxim Group Virtual Healthcare Conference |
2023-06-14 | Endocrine Society Meeting - Abstract #7680 |
2023-05-25 03:30 pm | Annual General Meeting |
2023-05-22 | Immunology of Diabetes Society Meeting |
2023-05-04 04:30 pm | Q1 2023 Earnings Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -25,6 -23,5 -9.14% | -27,6 |
EBIT Million USD | Released Forecast Spread | 0,00 | -5,75 -5,66 -1.7% | -10,0 -9,08 -10.24% | -34,1 -32,7 -4.21% | -25,6 -23,4 -9.67% | -27,6 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -5,06 -5,60 9.63% | -10,6 -9,49 -11.92% | -35,0 -34,1 -2.86% | -25,4 -23,3 -9.23% | -27,5 |
Net income Million USD | Released Forecast Spread | -6,20 | -4,77 -5,34 10.77% | -10,1 -8,78 -15.38% | -34,9 -34,1 -2.51% | -25,3 -23,1 -9.29% | -27,4 |
EPS USD | Released Forecast Spread | -26 160 | -14 880 -17 040 12.68% | -20 880 -18 160 -14.98% | -40 746 -1 459 201 97.21% | -317 -2 229 85.8% | -8,38 |
Announcement Date | 24/03/20 | 25/03/21 | 24/03/22 | 16/03/23 | 26/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
EBITDA Million USD | Released Forecast Spread | -4,86 -5,30 8.3% | -5,88 -5,30 -10.89% | -7,85 -5,90 -32.98% | -7,05 -4,90 -43.82% | -6,73 -6,30 -6.76% | -6,70 | -6,80 | -7,40 | ||||
EBIT Million USD | Released Forecast Spread | -4,00 -3,56 -12.54% | -3,59 -3,52 -1.97% | -3,62 -4,37 17.04% | -5,12 -3,80 -34.7% | -4,86 -5,09 4.53% | -5,88 -5,08 -15.78% | -7,85 -6,08 -28.99% | -7,05 -4,80 -46.97% | -6,73 -6,63 -1.48% | -6,69 | -6,76 | -6,83 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,70 -3,51 -5.33% | -22,1 -3,52 -529.74% | -4,46 -4,37 -2.08% | -4,75 -3,80 -24.76% | -5,11 -5,11 -0.01% | -5,98 -5,22 -14.63% | -7,85 -5,97 -31.6% | -6,51 -4,68 -39.06% | -7,26 -6,39 -13.51% | -6,50 | -6,60 | -7,20 |
Net income Million USD | Released Forecast Spread | -3,67 -3,40 -7.78% | -22,1 -3,45 -542.26% | -4,40 -4,37 -0.8% | -4,73 -3,80 -24.42% | -5,11 -5,11 -0.14% | -5,83 -5,22 -11.81% | -7,83 -5,97 -31.28% | -6,49 -4,68 -38.65% | -7,12 -6,39 -11.35% | -6,50 | -6,60 | -7,20 |
EPS USD | Released Forecast Spread | -6 480 -6 120 -5.88% | -36 240 -6 080 -496.05% | -5 040 -5 280 4.55% | -3 408 -86 400 96.06% | -390 -322 -21.12% | -159 -94,1 -68.97% | -53,8 -41,2 -30.58% | -65,9 -217 69.63% | -2,28 -1,62 -40.74% | -2,07 | -2,07 | -1,98 |
Announcement Date | 12/05/22 | 15/08/22 | 10/11/22 | 16/03/23 | 04/05/23 | 10/08/23 | 09/11/23 | 26/03/24 | 15/05/24 | - | - | - |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Panbela Therapeutics, Inc.
2024-06-07 02:57 am | POLARIS GROUP: May 2024 Sales and Revenue Release |
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SNBP Stock
- Calendar Panbela Therapeutics, Inc.